SanBio Co (TSE:4592) Other Net Income (Loss) : 円-0.00 Mil (TTM As of Jan. 2024)

View and export this data going back to 2015. Start your Free Trial

What is SanBio Co Other Net Income (Loss)?

SanBio Co's Other Net Income (Loss) for the three months ended in Jan. 2024 was 円-0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jan. 2024 was 円-0.00 Mil.

SanBio Co's quarterly Other Net Income (Loss) declined from Jul. 2023 (円0.00 Mil) to Oct. 2023 (円-0.00 Mil) but then increased from Oct. 2023 (円-0.00 Mil) to Jan. 2024 (円-0.00 Mil).

SanBio Co's annual Other Net Income (Loss) stayed the same from Jan. 2022 (円0.00 Mil) to Jan. 2023 (円0.00 Mil) but then declined from Jan. 2023 (円0.00 Mil) to Jan. 2024 (円-0.00 Mil).

SanBio Co Other Net Income (Loss) Historical Data

The historical data trend for SanBio Co's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SanBio Co Other Net Income (Loss) Chart

SanBio Co Annual Data

Trend

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Jan24

Other Net Income (Loss)

Get a 7-Day Free Trial

SanBio Co Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

SanBio Co Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-0.00 Mil.

SanBio Co Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of SanBio Co's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

SanBio Co (TSE:4592) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SanBio Co Ltd (TSE:4592) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

SNBIF:USA

Address

8-1 Street Luke Tower 32nd Floor, Akashi-cho, Chuo-ku, Tokyo, JPN, 104-0044

Website

https://www.sanbio.com

SanBio Co Ltd is engaged in the research and development of regenerative cells drugs. The company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; enhanced type-mesenchymal stem cells SB618, used to treat peripheral neuropathy, as well as muscle stem cells SB308, used in the treatment of muscular dystrophy.

SanBio Co (TSE:4592) Headlines

No Headlines